Antimicrobial resistance is the ability of microbes, such as bacteria, viruses, parasites, or fungi, to grow in the presence of a chemical (drug) that would normally kill it or limit its growth.
AAPA Policy
Misuse and overuse of antimicrobial agents have exacerbated the problem and include inappropriate prescribing by clinicians, expectation, demand for, and poor com
pliance by patients, and availability of antimicrobial agents without a prescription in many developing countries. Read more in AAPA's policy paper on antimicrobial resistance.
Partner Campaigns
Get Smart: Know When Antibiotics Work
National MRSA Education Initiative: Preventing MRSA Skin Infections
Prevent Antimicrobial Resistance: A Campaign for Clinicians in Healthcare Settings
Other Resources
Controlling Antimicrobial Resistance in Hospitals: Infection Control and Use of Antibiotics
Food and Drug Administration (FDA)
Healthcare-Associated Methicillin Resistant Staphylococcus Aureus (HA-MRSA)
Infectious Disease Society (IDSA): Bad Bugs No Drugs
Management of Multidrug-Resistant Organisms In Healthcare Settings, 2006
National Foundation of Infectious Disease
National Institute of Health (NIH)
National Nosocomial Infections Surveillance System (NNIS)
Prevention & Control of Antimicrobial Resistance Center for Disease Control and Prevention
Society for Healthcare Epidemiology (SHEA)
Supplement Article: SHEA/IDSA Practice Recommendation Strategies to Prevent Transmission of Methicillin Resistant Staphylococcus Aureus in Acute Care Hospitals
World Health Organization (WHO) Drug resistance
